The large-scale randomized clinical trials targeting pharmacological agents such as niacin and cholesteryl ester transfer protein inhibitors have shown that rising endogenous HDL-C does not improve cardiovascular outcomes or all-cause mortality 100,101,102
Most available safety data indicates that GHK-Cu peptide injections are generally safe to use under medical supervision, and adverse effects are generally mild
The abdominal wall has significantly higher subcutaneous blood flow
Cardiovascular safety trial demonstrating that the DPP-4 inhibitor alogliptin does not increase MACE in patients with T2DM who had a recent acute coronary event
Published Mar 24, 2026 5 minute read Found in every cell, this powerful antioxidant is perhaps our body's best immune regulator , and boosting its production can help calm the effects of autoimmunity., In this post, well dig into the many benefits of glutathione and some of the forms it takes in our practice